Erectile dysfunction Pipeline Highlights – 2017 – Research and Markets

Sigue a La Raza en Facebook

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Erectile
dysfunction Pipeline Highlights – 2017”
drug pipelines to their
offering.

This report, Erectile dysfunction Pipeline Highlights – 2017, provides
most up-to-date information on key pipeline products in the global
Erectile dysfunction market. It covers emerging therapies for Erectile
dysfunction in active clinical development stages including early and
late stage clinical trials. The pipeline data presented in this report
helps executives for tracking competition, identifying partners,
evaluating opportunities, formulating business development strategies,
and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Erectile dysfunction pipeline products by clinical
trial stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Erectile dysfunction pipeline products by their
dominant mechanism of action. This helps executives categorize products
based on their drug class and also assess the strengths and weaknesses
of compounds.

Company:

The report provides Erectile dysfunction pipeline products by the
company.

Short-term Launch Highlights:

Find out which Erectile dysfunction pipeline products will be launched
in the US and Ex-US till 2020.

Summary:

  • Erectile dysfunction phase 3 clinical trial pipeline products
  • Erectile dysfunction phase 2 clinical trial pipeline products
  • Erectile dysfunction phase 1 clinical trial pipeline products
  • Erectile dysfunction preclinical research pipeline products
  • Erectile dysfunction discovery stage pipeline products
  • Erectile dysfunction pipeline products short-term launch highlights

Key Topics Covered:

1. Erectile dysfunction Pipeline by Stages

2. Erectile dysfunction Pipeline by Drug Class

3. Erectile dysfunction Pipeline by Company

4. Erectile dysfunction Phase 3 Clinical Trial Insights

5. Erectile dysfunction Phase 2 Clinical Trial Insights

6. Erectile dysfunction Phase 1 Clinical Trial Insights

7. Erectile dysfunction Preclinical Research Insights

8. Erectile dysfunction Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/p9lclz/erectile

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Sexual
and Reproductive Health Drugs